Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era

[1]  A. Wein,et al.  Campbell-Walsh Urology , 2011 .

[2]  A. Horwich,et al.  EAU guidelines on testicular cancer: 2011 update. , 2011, European urology.

[3]  G. Duncan,et al.  Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  G. Pond,et al.  Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience. , 2011, European urology.

[5]  G. Rustin,et al.  Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Y. Miyasaka,et al.  A study of the assessment of axillary lymph nodes before surgery for breast cancer using multidetector-row computed tomography , 2010, Surgery Today.

[7]  R. Bremnes,et al.  Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  M. Gleave,et al.  Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  M. Jewett,et al.  Surveillance in stage I nonseminomatous germ cell tumours of the testis , 2009, BJU international.

[10]  I. Narabayashi,et al.  Preoperative Evaluation of Local Invasion and Metastatic Lymph Nodes of Colorectal Cancer and Mesenteric Vascular Variations Using Multidetector-Row Computed Tomography Before Laparoscopic Surgery , 2007, Journal of computer assisted tomography.

[11]  L. Paz-Ares,et al.  Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  M. Urashima,et al.  Clinical value of multidetector row computed tomography in detecting lymph node metastasis of early gastric cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  M. Mason,et al.  Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review. , 2002, Cancer treatment reviews.

[14]  F. Algaba,et al.  EAU Guidelines on Testicular Cancer , 2001, European Urology.

[15]  N. Summers,et al.  Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. , 1998, The Journal of urology.

[16]  M. Williams,et al.  Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Paus,et al.  Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA). , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  T. Gilligan,et al.  Neoplasms of the Testis , 2012 .

[19]  L. Mazzucchelli,et al.  Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. , 1993, European urology.